And patients themselves didnt seem to care how the drugs worked or how bad the side effects were
The clinical significance of this effect is not fully characterized, but some providers recommend that women on oral contraceptives switch to a non-oral method (patch, ring, IUD, implant) when starting GLP-1 therapy, or use backup contraception during the titration period
Lifestyle Factors If your diet is still high in processed foods, sugary drinks, or refined carbs, the medications appetitesuppressing effects may not be enough
Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Johnson & Johnson, Bristol-Myers Squibb Company are some of the key market players in the semaglutide market